GOLDMAN SACHS GROUP INC - TETRAPHASE PHARMACEUTICALS I ownership

TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 107 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q3 2015. The put-call ratio across all filers is 1.99 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of TETRAPHASE PHARMACEUTICALS I
ValueSharesWeighting
Q2 2019$183,000
+7.0%
380,978
+198.6%
0.00%
Q1 2019$171,000
-26.6%
127,580
-38.2%
0.00%
Q4 2018$233,000
-58.6%
206,502
+1.3%
0.00%
Q3 2018$563,000
-23.3%
203,918
-0.8%
0.00%
Q2 2018$734,000
+25.9%
205,585
+8.2%
0.00%
Q1 2018$583,000
-17.8%
190,015
+68.9%
0.00%
Q4 2017$709,000
+19.0%
112,524
+29.3%
0.00%
Q3 2017$596,000
+322.7%
87,051
+467.6%
0.00%
Q1 2017$141,000
+11.0%
15,337
-51.5%
0.00%
Q4 2016$127,000
-20.6%
31,595
-24.2%
0.00%
Q3 2016$160,000
-44.6%
41,680
-38.1%
0.00%
Q2 2016$289,000
-42.9%
67,302
-38.4%
0.00%
Q1 2016$506,000
-79.7%
109,193
-56.2%
0.00%
-100.0%
Q4 2015$2,498,000
+577.0%
249,067
+403.6%
0.00%
Q3 2015$369,000
-20.0%
49,458
+409.2%
0.00%
Q2 2015$461,000
+45.4%
9,712
-38.8%
0.00%
Q3 2014$317,000
+8.2%
15,867
-41.1%
0.00%
Q1 2014$293,000
-21.0%
26,943
-1.8%
0.00%
Q4 2013$371,00027,4460.00%
Other shareholders
TETRAPHASE PHARMACEUTICALS I shareholders Q3 2015
NameSharesValueWeighting ↓
683 Capital Management, LLC 600,000$2,142,0000.14%
Tekla Capital Management LLC 859,322$3,068,0000.12%
DOW CHEMICAL CO /DE/ 65,000$232,0000.08%
Candriam S.C.A. 495,613$1,769,0000.03%
A.R.T. Advisors, LLC 174,335$622,0000.02%
Baker Brothers Advisors 935,000$3,338,0000.02%
FLAGSHIP HARBOR ADVISORS, LLC 29,400$104,0000.02%
Alambic Investment Management, L.P. 17,804$64,0000.02%
Teton Advisors, Inc. 44,000$157,0000.01%
Man Group plc 737,715$2,634,0000.01%
View complete list of TETRAPHASE PHARMACEUTICALS I shareholders